Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BRC-002 for Idiopathic Restless Legs Syndrome
NCT07224932Phase 2Not yet recruiting
- Sponsor
- University of Colorado Denver
- Start
- Nov 2026
- Primary completion
- Mar 2028
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of BRC-002 in restless legs syndrome (RLS), sponsored by University of Colorado Denver. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
BRC-002
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT07224932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07224932.